Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Tsuruha HoldingsTSUSF 47 EV-to-EBIT is 13.46 as of Jul. 23, 2026, which is 2% above its 10-year median of 13.26. GuruFocus rates TSUSF with a GF Score™ of 47/100 and a GF Value™ of $11.49. The stock has 6 warning signs investors should review. Among 468 Healthcare Providers & Services companies, Tsuruha Holdings ranks better than 57.26% on this metric.
The historical rank and industry rank for Tsuruha Holdings's EV-to-EBIT or its related term are showing as below:
TSUSF'
s EV-to-EBIT Range Over the Past 10 Years
Min: 6.92 Med: 13.26 Max: 20.42
Current: 14.1
During the past 13 years, the highest EV-to-EBIT of Tsuruha Holdings was 20.42. The lowest was 6.92. And the median was 13.26.
TSUSF's EV-to-EBIT is ranked better than 57.26% of 468
companies
in the Healthcare Providers & Services industry
Industry Median: 15.775
vs TSUSF: 14.10
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Tsuruha Holdings's Enterprise Value for the quarter that ended in Feb. 2026 was $7,983 Mil.
Tsuruha Holdings's EBIT for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $492 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tsuruha Holdings EV-to-EBIT Related Terms
Tsuruha Holdings EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Tsuruha Holdings's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Tsuruha Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tsuruha Holdings EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Tsuruha Holdings's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Tsuruha Holdings's EV-to-EBIT falls into.
Tsuruha Holdings's current Enterprise Value is $6,623 Mil.
Tsuruha Holdings's EBIT for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $492 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tsuruha Holdings (TSUSF) has a EV-to-EBIT of 13.46 as of Jul. 23, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Tsuruha Holdings and its competitors. This is near median its historical median of 13.26. Over the past decade, Tsuruha Holdings' EV-to-EBIT has ranged from 6.92 to 20.42. According to the industry distribution chart, Tsuruha Holdings ranks #200 out of 468 companies in the Healthcare Providers & Services industry, placing it in the top 42.7%.
Is Tsuruha Holdings' EV-to-EBIT too high?
Tsuruha Holdings' current EV-to-EBIT of 13.46 is near median its 10-year median of 13.26. Over the past 10 years, this metric has ranged from a low of 6.92 to a high of 20.42. The Healthcare Providers & Services industry median EV-to-EBIT is 15.78. Tsuruha Holdings' value of 13.46 is 14.7% below this industry median. Based on the distribution chart, Tsuruha Holdings ranks #200 out of 468 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Tsuruha Holdings has a GF Score™ of 47/100, reflecting its overall financial health beyond just this single metric.
How does Tsuruha Holdings' EV-to-EBIT compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Tsuruha Holdings ranks #200 out of 468 companies for EV-to-EBIT. This puts Tsuruha Holdings in the upper half of its industry. The industry median EV-to-EBIT is 15.78. Tsuruha Holdings' value of 13.46 is 14.7% below this benchmark. Historically, Tsuruha Holdings' own EV-to-EBIT has ranged from 6.92 to 20.42 over the past decade. While the company's 10-year median is 13.26 vs. the industry median of 15.78, Tsuruha Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.78, based on 468 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tsuruha Holdings's current EV-to-EBIT of 13.46 is 14.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Tsuruha Holdings and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tsuruha Holdings's current EV-to-EBIT is 13.46, which is near median its own 10-year median of 13.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tsuruha Holdings stock overvalued right now?
Tsuruha Holdings (TSUSF) has a current EV-to-EBIT of 13.46. The stock's GF Value™ is $11.49, compared to a current price of $17.25 — trading 50.1% above its estimated fair value. The current EV-to-EBIT is 13.46, which is near median its 10-year median of 13.26 and 14.7% below the Healthcare Providers & Services industry median of 15.78. Tsuruha Holdings' overall GF Score™ is 47/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Tsuruha Holdings (TSUSF), the current EV-to-EBIT is 13.46 as of Jul. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tsuruha Holdings (TSUSF) Overvalued in 2026?
Based on GuruFocus' analysis, Tsuruha Holdings stock appears to be overvalued.
The current stock price of $17.25 is trading 50.1% above its estimated GF Value™ of $11.49.
Key valuation signals for TSUSF:
EV-to-EBIT: 13.46 (near median its 10-year median of 13.26)
GF Value™: $11.49 vs. price of $17.25 (50.1% above fair value)
Industry Position: 14.7% below the Healthcare Providers & Services median (#200 of 468)
No single metric tells the full story. See the TSUSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tsuruha Holdings Inc manages pharmaceutical companies in Japan, where the drugstore business is the core of their operations. The company generates revenue through selling prescription and over-the-counter drugs, medical supplies, nursing care products, discount cosmetics, health products, and a miscellaneous assortment of general merchandise. It also provides blood testing services, disease prevention solutions, and at-home drug delivery services.
47GF Score
Get the complete analysis for TSUSF
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSUSF has been successfully added to your 
